Cabergoline Tablet
Product Images NDC 59762-1005
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Cabergoline (NDC 59762-1005). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Logo (Cabergoline 02)
Principal Display Panel (8 Tablet Bottle Label)
This is a description of a medication labeled as NDC 59762-1005-1. The medication is in the form of eight tablets manufactured under the Greenstone brand containing 0.5mg cabergoline per tablet. It is advised to store the medication at controlled room temperature between 20° to 25°C (68° to 77°F) and the dosage and use should be in line with the prescribing information accompanying the medication. The product is distributed by Greenstone LLC, located in Peapack, NJ 07977 and it was made in Italy. The batch number reads LOT/EXP K2.*
Principal Display Panel (8 Tablet Bottle Carton)
This is a product description for Greenstone brand Cabergoline tablets with a dosage strength of 0.5 mg. The tablets come in a bottle containing eight tablets, and the packaging includes directions for use, prescribing information, and storage. The text also includes various codes and numbers, including a product code (GTIN), a manufacturing code, and a controlled room temperature range.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.